Related Experiment Video
Updated: Aug 24, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
Comparison of WNK4 and WNK1 kinase and inhibiting activities
Zhaohong Wang1, Chao-Ling Yang, David H Ellison
1Division of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, Portland, OR 97239, USA.
Abstract:
WNK kinases are novel serine/threonine protein kinases. Mutations in two members of the WNK family, WNK1 and WNK4, cause familial hyperkalemic hypertension. These kinases regulate ion transport across diverse epithelia; WNK4 reduces activity of the Na-Cl cotransporter activity and the potassium channel, ROMK, by reducing their appearance at the plasma membrane. We examined the kinase activity of WNK1 and WNK4 in vitro. A glutathione S-transferase (GST) fusion protein of the WNK1 kinse domain phosphorylated itself and a substrate protein, as reported previously. A longer construct, containing the autoinhibitory domain, did not. A GST WNK4 kinase domain construct demonstrated no kinase activity, in vitro or in HEK 293 cells. WNK4 constructs that included a region homologous to the autoinhibitory domain of WNK1 inhibited WNK1 kinase activity. Inhibition by a short WNK4 segment, WNK4 (444-518), was greater than inhibition by WNK4 (444-563). Together, these results suggest that WNK4 must be activated by currently unknown factors to exhibit kinase activity and that WNK4 contains an inhibitory domain that can inhibit the kinase activity of WNK1.
Insights
WNK4 requires activation for kinase activity and can inhibit WNK1. This research explores WNK kinase regulation in ion transport and hypertension.
Area of Science:
- Biochemistry
- Molecular Biology
- Physiology
Background:
- WNK kinases (WNK1, WNK4) are serine/threonine protein kinases implicated in familial hyperkalemic hypertension.
- Mutations in WNK1 and WNK4 disrupt ion transport, affecting epithelial function.
- WNK4 regulates the Na-Cl cotransporter and ROMK potassium channel by controlling their plasma membrane localization.
Purpose of the Study:
- To investigate the in vitro kinase activity of WNK1 and WNK4.
- To identify regulatory domains within WNK1 and WNK4.
- To understand the inhibitory interactions between WNK4 and WNK1.
Main Methods:
- In vitro kinase assays using glutathione S-transferase (GST) fusion proteins of WNK1 and WNK4 domains.
- Expression and analysis of WNK constructs in HEK 293 cells.
- Assessment of WNK4's inhibitory effect on WNK1 kinase activity.
Main Results:
- The WNK1 kinase domain exhibited autophosphorylation and substrate phosphorylation.
- A longer WNK1 construct with an autoinhibitory domain lacked kinase activity.
- WNK4 kinase domain constructs showed no detectable kinase activity in vitro or in cells.
- WNK4 segments homologous to WNK1's autoinhibitory domain inhibited WNK1 kinase activity, with WNK4 (444-518) being more potent.
Conclusions:
- WNK4 requires activation by unknown factors to become catalytically active.
- WNK4 possesses an inhibitory domain capable of suppressing WNK1 kinase activity.
- These findings provide insights into the complex regulation of WNK kinases and their role in ion homeostasis and hypertension.
Related Concept Videos
Inhibition of CDK Activity
Inhibition of Cdk Activity
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Enzyme Inhibition

